Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
주식 순위 #25697
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
주가
$2.09
마지막 동기화: 2022-03-21
시가총액
$47.04M
변동 (1일)
-0.48%
변동 (1년)
0.00%
국가
US
거래 Recro Pharma, Inc. (REPH)

카테고리

Recro Pharma, Inc. (REPH)의 EPS
2026 기준 EPS TTM: 0
Recro Pharma, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Recro Pharma, Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.